首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >Comparison between 5-day aprepitant and single-dose fosaprepitant meglumine for preventing nausea and vomiting induced by cisplatin-based chemotherapy
【24h】

Comparison between 5-day aprepitant and single-dose fosaprepitant meglumine for preventing nausea and vomiting induced by cisplatin-based chemotherapy

机译:五天阿瑞匹坦和单剂量福沙瑞汀葡甲胺预防基于顺铂的化学疗法引起的恶心和呕吐的比较

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose We aimed to compare the preventive effect of 5-day administration of aprepitant with single administration of fosaprepitant meglumine against nausea and vomiting symptoms due to highly emetogenic chemotherapy regimens comprising cisplatin (CDDP).
机译:目的我们的目的是比较5天服用阿瑞匹坦和单次服用fosaprepitant葡甲胺对由于包含顺铂(CDDP)的高致呕性化疗方案而引起的恶心和呕吐症状的预防效果。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号